Literature DB >> 18385244

Human immunodeficiency virus type 1 Vpr binds to the N lobe of the Wee1 kinase domain and enhances kinase activity for CDC2.

Masakazu Kamata1, Nobumoto Watanabe, Yoshiko Nagaoka, Irvin S Y Chen.   

Abstract

Human immunodeficiency virus type 1 Vpr is a virion-associated accessory protein that has multiple activities within an infected cell. One of the most dramatic effects of Vpr is the induction of cell cycle arrest at the G(2)/M boundary, followed by apoptosis. This effect has implications for CD4(+) cell loss in AIDS. In normal cell cycle regulation, Wee1, a key regulator for G(2)-M progression, phosphorylates Tyr15 on Cdc2 and thereby blocks the progression of cells into M phase. We demonstrate that Vpr physically interacts with Wee1 at the N lobe of the kinase domain analogous to that present in other kinases. This interaction with Vpr enhances Wee1 kinase activity for Cdc2. Overexpression of Wee1 kinase-deficient mutants competes for Vpr-mediated cell cycle arrest, and deletion of the region of Wee1 that binds Vpr abrogates that competition. However, the Vpr mutants I74P and I81P, which fail to induce G(2) arrest, can bind to and increase the kinase activity of Wee1 to the same extent as wild-type Vpr. Therefore, we conclude that the binding of Vpr to Wee1 is not sufficient for Vpr to activate the G(2) checkpoint, and it may reflect an independent function of Vpr.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18385244      PMCID: PMC2395134          DOI: 10.1128/JVI.01330-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  60 in total

1.  Binding of 14-3-3beta to the carboxyl terminus of Wee1 increases Wee1 stability, kinase activity, and G2-M cell population.

Authors:  Y Wang; C Jacobs; K E Hook; H Duan; R N Booher; Y Sun
Journal:  Cell Growth Differ       Date:  2000-04

2.  HIV-1 genome nuclear import is mediated by a central DNA flap.

Authors:  V Zennou; C Petit; D Guetard; U Nerhbass; L Montagnier; P Charneau
Journal:  Cell       Date:  2000-04-14       Impact factor: 41.582

3.  The human immunodeficiency virus type 2 vpr gene is essential for productive infection of human macrophages.

Authors:  N Hattori; F Michaels; K Fargnoli; L Marcon; R C Gallo; G Franchini
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

4.  Depletion of Wee-1 kinase is necessary for both human immunodeficiency virus type 1 Vpr- and gamma irradiation-induced apoptosis.

Authors:  Huidong Yuan; Yi-Ming Xie; Irvin S Y Chen
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

5.  Human immunodeficiency virus type 1 vpr induces apoptosis through caspase activation.

Authors:  S A Stewart; B Poon; J Y Song; I S Chen
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

6.  Identification of HIV-1 vpr product and function.

Authors:  E A Cohen; E F Terwilliger; Y Jalinoos; J Proulx; J G Sodroski; W A Haseltine
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

7.  Genetic studies with the fission yeast Schizosaccharomyces pombe suggest involvement of wee1, ppa2, and rad24 in induction of cell cycle arrest by human immunodeficiency virus type 1 Vpr.

Authors:  M Masuda; Y Nagai; N Oshima; K Tanaka; H Murakami; H Igarashi; H Okayama
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

Review 8.  Could Nef and Vpr proteins contribute to disease progression by promoting depletion of bystander cells and prolonged survival of HIV-infected cells?

Authors:  A A Azad
Journal:  Biochem Biophys Res Commun       Date:  2000-01-27       Impact factor: 3.575

9.  A carboxy-terminally truncated form of the human immunodeficiency virus type 1 Vpr protein induces apoptosis via G(1) cell cycle arrest.

Authors:  M Nishizawa; M Kamata; R Katsumata; Y Aida
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

10.  Open reading frame vpr of simian immunodeficiency virus encodes a virion-associated protein.

Authors:  X F Yu; M Matsuda; M Essex; T H Lee
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

View more
  12 in total

1.  HIV-1 Vpr loads uracil DNA glycosylase-2 onto DCAF1, a substrate recognition subunit of a cullin 4A-ring E3 ubiquitin ligase for proteasome-dependent degradation.

Authors:  Jinwoo Ahn; Thomas Vu; Zach Novince; Jennifer Guerrero-Santoro; Vesna Rapic-Otrin; Angela M Gronenborn
Journal:  J Biol Chem       Date:  2010-09-24       Impact factor: 5.157

Review 2.  Viral manipulation of DNA repair and cell cycle checkpoints.

Authors:  Mira S Chaurushiya; Matthew D Weitzman
Journal:  DNA Repair (Amst)       Date:  2009-05-26

Review 3.  Cell cycle regulation during viral infection.

Authors:  Sumedha Bagga; Michael J Bouchard
Journal:  Methods Mol Biol       Date:  2014

Review 4.  Vpr-host interactions during HIV-1 viral life cycle.

Authors:  Richard Y Zhao; Ge Li; Michael I Bukrinsky
Journal:  J Neuroimmune Pharmacol       Date:  2011-02-12       Impact factor: 4.147

5.  Human herpesvirus 6 suppresses T cell proliferation through induction of cell cycle arrest in infected cells in the G2/M phase.

Authors:  Lingyun Li; Bin Gu; Feng Zhou; Jing Chi; Fang Wang; Guangyong Peng; Fangyi Xie; Jian Qing; Dongju Feng; Shiqiang Lu; Kun Yao
Journal:  J Virol       Date:  2011-04-27       Impact factor: 5.103

6.  Virion-associated Vpr of human immunodeficiency virus type 1 triggers activation of apoptotic events and enhances fas-induced apoptosis in human T cells.

Authors:  Hubert Arokium; Masakazu Kamata; Irvin Chen
Journal:  J Virol       Date:  2009-08-19       Impact factor: 5.103

Review 7.  Yeast for virus research.

Authors:  Richard Yuqi Zhao
Journal:  Microb Cell       Date:  2017-09-18

Review 8.  Breaking Bad: How Viruses Subvert the Cell Cycle.

Authors:  Ying Fan; Sumana Sanyal; Roberto Bruzzone
Journal:  Front Cell Infect Microbiol       Date:  2018-11-19       Impact factor: 5.293

9.  Reassessing the role of APOBEC3G in human immunodeficiency virus type 1 infection of quiescent CD4+ T-cells.

Authors:  Masakazu Kamata; Yoshiko Nagaoka; Irvin S Y Chen
Journal:  PLoS Pathog       Date:  2009-03-20       Impact factor: 6.823

Review 10.  HIV-1 Vpr-a still "enigmatic multitasker".

Authors:  Carolin A Guenzel; Cécile Hérate; Serge Benichou
Journal:  Front Microbiol       Date:  2014-03-31       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.